These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2293805)

  • 1. Increasing rubella seronegativity despite a compulsory school law.
    Schum TR; Nelson DB; Duma MA; Sedmak GV
    Am J Public Health; 1990 Jan; 80(1):66-9. PubMed ID: 2293805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a two-dose measles, mumps, and rubella vaccination schedule in a cohort of college athletes.
    Coté TR; Sivertson D; Horan JM; Lindegren ML; Dwyer DM
    Public Health Rep; 1993; 108(4):431-5. PubMed ID: 8341775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rubella seronegativity in a low socioeconomic adolescent female population.
    Cohen ZB; Rice LI; Felice ME
    Clin Pediatr (Phila); 1985 Jul; 24(7):387-90. PubMed ID: 4006350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunoglobulin response to reimmunization with rubella vaccine.
    Scott RM; Schydlower M; Lampe RM; Schwab JA; Muelenaer AA
    J Pediatr; 1981 Oct; 99(4):531-4. PubMed ID: 7277092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High rubella seronegativity in daycare educators.
    Gyorkos TW; Béliveau C; Rahme E; Muecke C; Joseph S; Soto JC
    Clin Invest Med; 2005 Jun; 28(3):105-11. PubMed ID: 16021983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rubella screening and immunization of health care personnel: critical appraisal of a voluntary program.
    Hartstein AI; Quan MA; Williams ML; Osterud HT; Foster LR
    Am J Infect Control; 1983 Feb; 11(1):1-9. PubMed ID: 6551147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of chronic arthropathy among women after rubella vaccination. Vaccine Safety Datalink Team.
    Ray P; Black S; Shinefield H; Dillon A; Schwalbe J; Holmes S; Hadler S; Chen R; Cochi S; Wassilak S
    JAMA; 1997 Aug; 278(7):551-6. PubMed ID: 9268275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on live rubella vaccine. VI. Seroepidemiological surveillance and immunization of adolescents in high school.
    Minekawa Y; Takahashi M; Ueda S; Ogino T
    Biken J; 1975 Sep; 18(3):149-54. PubMed ID: 1191245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination of seronegative high-risk populations with attenuated rubella vaccine.
    Lehtinen MO; Hakkarainen K; Leinikki PO; Lehtinen TK; Mattila LM; Helle EP
    Ann Clin Res; 1982 Dec; 14(5-6):213-9. PubMed ID: 7171230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rubella seronegativity in antenatal screening - Is it influenced by the introduction of universal childhood rubella immunization?
    Lao TT; Sahota DS; Law LW; Leung TY
    Vaccine; 2015 Sep; 33(38):4776-81. PubMed ID: 26271826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rubella susceptibility in inner-city adolescents: the effect of a school immunization law.
    Nelson DB; Layde MM; Chatton TB
    Am J Public Health; 1982 Jul; 72(7):710-3. PubMed ID: 7091461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility to rubella and borderline immunity.
    Fogel A; Barnea B; Gerichter CB
    Isr J Med Sci; 1983 Oct; 19(10):934-5. PubMed ID: 6363349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of Immunity Acquired after a Single Dose of Rubella Vaccine in Japan.
    Okafuji T; Okafuji T; Nakayama T
    Jpn J Infect Dis; 2016 May; 69(3):221-3. PubMed ID: 26255735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the two-dose rubella vaccination regimen on incidence of rubella seronegativity in gravidae aged 25 years and younger.
    Hui SYA; Sahota DS; Lao TT
    PLoS One; 2017; 12(8):e0183630. PubMed ID: 28854204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rubella immunization--immunity after 4 years (author's transl)].
    Petersen EE; Neumann-Haefelin D; Kärnbach M; Haas R
    Dtsch Med Wochenschr; 1977 Jul; 102(26):954-8. PubMed ID: 885075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rubella immunization with HPV77DE5 and RA 27/3 vaccines of 11 to 16-year-old girls: studies of antibody formation and antibody resistance after 4 and 8 years].
    Gitmans U; Enders G; Glück H; Harm B; Lindemann L
    Immun Infekt; 1983 May; 11(3):79-90. PubMed ID: 6676174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of measles-rubella vaccination for mothers in early puerperal phase.
    Hisano M; Kato T; Inoue E; Sago H; Yamaguchi K
    Vaccine; 2016 Feb; 34(9):1208-14. PubMed ID: 26801065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing the rubella seronegativity in pregnant women who received one dose of rubella vaccine at different ages in Taiwan.
    Shih CT; Chang YC; Wang HL; Lin CC
    Vaccine; 2016 Sep; 34(40):4787-91. PubMed ID: 27544587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of rubella infection after national immunization program in Taiwan: vaccination status and immigration impact.
    Wang IJ; Huang LM; Chen HH; Hwang KC; Chen CJ
    J Med Virol; 2007 Jan; 79(1):97-103. PubMed ID: 17133552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunity to intranasal challenge with Rubella virus two years after vaccination: comparison of three vaccines.
    Grillner L
    J Infect Dis; 1976 Jun; 133(6):637-41. PubMed ID: 932491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.